Study Aims to Identify New Auditory Biomarkers
The SAPHIR study aims to develop auditory biomarkers for early detection and improved disease management related to cognitive decline.
Read MorePosted by Chris Wolski | Feb 19, 2025 | Dementias & Alzheimer’s |
The SAPHIR study aims to develop auditory biomarkers for early detection and improved disease management related to cognitive decline.
Read MorePosted by Andy Lundin | Jan 23, 2025 | Dementias & Alzheimer’s |
A new expert-led paper highlights the potential of biomarker testing to improve early diagnosis and treatment of synucleinopathies.
Read MorePosted by Andy Lundin | Jan 8, 2025 | Dementias & Alzheimer’s |
Researchers have visualized the atomic-level structure of protein clumps linked to Huntington’s disease, paving the way for diagnostic tools.
Read MorePosted by Andy Lundin | Dec 20, 2024 | Dementias & Alzheimer’s |
A new study demonstrates the clinical utility of a skin biopsy diagnostic tool in improving care for those with neurodegenerative diseases.
Read MorePosted by Andy Lundin | Nov 8, 2024 | Dementias & Alzheimer’s, Molecular Diagnostics |
Sunbird Bio demonstrated that its blood-based alpha synuclein biomarkers can accurately detect Parkinson’s disease.
Read More